Chronic oral administration of ibrutinib prevents long-term memory deficits and reduces AD pathology and neuroinflammatory responses in a mouse model of AD

ABSTRACT:

SUBMITTER: Lee H 

PROVIDER: S-EPMC12281740 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature